-
Catalogue Entry: Appearance of the Minister of Health Before HESA on the Supps B/Mandate Letter
Opening Statement Mandate Letter Supplementary Estimates B / Health Canada Portfolio Financial Overview-
File available for download in the following formats:
-
Catalogue Entry: Resources for Canadians living with pain during COVID-19: Resources
The Government of Canada and the Canadian Pain Task Force (CPTF) recognize Canadians living with chronic pain need additional supports during COVID-19. The following list of...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Conducting a clinical trial for COVID-19 medical devices: List of authorized...
The table below lists the clinical trials authorized by Health Canada for COVID-19-related medical devices.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: For an appearance before the House of Commons Standing Committee on Health ...
Briefing Binder used by the Deputy Minister of Health at an appearance before the Standing Committee on Health on March 31, 2020-
File available for download in the following formats:
-
Catalogue Entry: APPEARANCE OF THE MINISTER OF HEALTH
Briefing binder for the Minister of Health’s appearance at Committee of the Whole on April 20, 2020-
File available for download in the following formats:
-
Catalogue Entry: Briefing binder for the Minister of Health’s appearances at the Special...
Briefing binder for the Minister of Health’s appearances at the Special Committee on the COVID-19 Pandemic (COVI) – Week of April 28-
File available for download in the following formats:
-
Catalogue Entry: Collaboration with the Public Health Agency of Canada’s National Microbiology Lab
The Public Health Agency of Canada’s National Microbiology Lab (PHAC-NML) will conduct independent scientific laboratory evaluation of some COVID-19 testing devices when...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Health Canada’s regulatory response to COVID-19: Access to health products
Health Canada introduced innovative and agile regulatory measures. These measures expedite the regulatory review of COVID-19 health products without compromising safety,...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Health products that make false or misleading claims to prevent, treat or...
Health Canada is warning Canadians about the risks of purchasing health products that make unauthorized claims to prevent, treat or cure COVID-19.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Good Manufacturing Practices and COVID-19
Good manufacturing practices (GMP) ensure that drugs meet the quality standards appropriate to their intended use before they are sold.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Drug establishment licences and COVID-19
All Canadian drug establishments must have a drug establishment licence to fabricate, package/label, distribute, import, wholesale or test a drug as required under Part C,...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Regulatory considerations on the classification of non-medical masks or face...
This notice explains under which circumstances non-medical masks or face coverings would be subject to the regulatory framework for medical devices during the COVID-19 pandemic.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Special Committee on COVID
Briefing binder for the Minister of Health’s appearances at the Special Committee on the COVID-19 Pandemic (COVI) – Week of May 4, 2020-
File available for download in the following formats:
-
Catalogue Entry: Special Committee on COVID
Briefing binder for the Minister of Health’s appearances at the Special Committee on the COVID-19 Pandemic (COVI) – Week of May 11, 2020-
File available for download in the following formats:
-
Catalogue Entry: Special Committee on COVID
Briefing binder for the Minister of Health’s appearances at the Special Committee on the COVID-19 Pandemic (COVI) – Week of May 18, 2020-
File available for download in the following formats:
-
Catalogue Entry: Commons Standing Committee on Government Operations and Estimates COVID-19
Briefing binder for the Minister of Health’s appearances at the Standing Committee on Government Operations and Estimates (OGGO) COVID-19 – May 22, 2020-
File available for download in the following formats:
-
Catalogue Entry: Canada's Drug Supply Chain
The Canadian drug supply chain is complex, with distinct roles and responsibilities among many players including manufacturers, wholesalers, hospitals, health care practitioners...-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Causes of Drug Shortages in Canada
Drug shortages can occur for any number of reasons and can result from problems at any point in the drug supply chain.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Regulatory decision summaries of drugs and health products
Understand the decisions to approve or not approve the sale of drugs and medical devices in Canada.-
File available for download in the following formats:
- HTML
-
Catalogue Entry: Drug and Health Product Submissions Under Review (SUR)
Present the list of new drug submissions (NDSs) that are currently being reviewed.-
File available for download in the following formats:
- HTML